No summary provided for this position.

The CeMM Pre-ERC Postdoc Program at the Medical University of Vienna and CeMM Research Center for Molecular Medicine is recruiting postdoctoral researchers in the fields of systems biology, immunity, cancer, bioinformatics, biomedical machine learning, artificial intelligence, CRISPR, single-cell analysis, spatial biology, and cell programming. The program is designed for ambitious scientists aiming to pursue independent research careers and competitive grants such as the ERC Starting Grant. Three main candidate profiles are sought: (1) experimental systems biology in immunity or cancer, (2) bioinformatics and biomedical ML/AI, and (3) technology development and bioengineering (including CRISPR, single-cell, spatial, and cell programming). Candidates with expertise in any combination of these areas are encouraged to apply. The group welcomes applicants from both wet-lab and computational backgrounds, including those interested in organoids, mouse models, or methods development in ML/AI. The research group, led by Christoph Bock, is highly interdisciplinary and collaborative, with a strong focus on advancing molecular medicine. Recent research highlights include immune regulation by non-immune cells, CRISPR-optimized CAR T cell immunotherapy, epigenetic tumor heterogeneity, high-content CRISPR screening, and chat-based single-cell data analysis. More information about ongoing projects and research interests can be found at bocklab.org and med-ai.org . The CeMM Pre-ERC Postdoc Program offers a fully funded, competitive training environment with individualized mentoring, expert-led seminars, and hands-on supervision. The program is based in Vienna, Austria, and is supported by institutional partners including the Medical University of Vienna and the St. Anna Children’s Cancer Research Institute. The current application call is for the spring session, with a deadline of August 1, 2026. Applicants should have a PhD in a relevant field and a strong track record in research. Creativity, ambition, and the ability to propose an independent research direction are highly valued. For further details and to apply, visit the official program page at cemm.at/postdoc-program and the application portal linked in the announcement.

The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and the Medical University of Vienna are recruiting PhD students through the AITHYRA-CeMM PhD Program. The group, led by Professor Christoph Bock, is highly interdisciplinary and collaborative, focusing on advancing molecular medicine through systems biology, bioinformatics, biomedical machine learning/AI, and bioengineering. Research areas include experimental systems biology in immunity and cancer, bioinformatics and ML/AI methods development, and technology development in bioengineering (CRISPR, single-cell, spatial biology, cell programming, organoids, and mouse models). Recent research highlights include immune regulation by non-immune cells, CRISPR-optimized CAR T cell immunotherapy, epigenetic tumor heterogeneity, high-content CRISPR screening, and chat-based single-cell data analysis. The group welcomes candidates from wet-lab, computational, or mixed backgrounds, and encourages applicants to propose their own research ideas as part of the application process. Applicants should have a strong background in relevant fields and a keen interest in molecular medicine, systems biology, and cutting-edge technologies. The program typically offers fully funded PhD positions, but candidates should confirm funding details via the application portal. For further information and to apply, visit https://apply.cemm.at . Keywords: systems biology, immunity, cancer, bioinformatics, biomedical machine learning, artificial intelligence, CRISPR, single-cell, spatial biology, cell programming, organoids, mouse models, epigenomics, tumor heterogeneity.